Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

Release Date: January 31, 2023

Expiration Date: January 31, 2024

Part 1 Activity Overview
This Burst CME: Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC is an interview-based program in which an expert discusses the importance of genetic testing in patients with non–small cell lung cancer (NSCLC). It is recommended that patients with NSCLC are tested for actionable biomarkers prior to immunotherapy treatment to ensure the best response. This will be presented in a multimedia format, including audio interviews integrated into text-based elements.

Target Audience

This educational activity is directed toward medical oncologists, pathologists, nurses, and other oncology health care professionals.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe testing methods and relevant targets that may be used to inform clinical decisions in patients with NSCLC and fusions of ROS1 or NTRK
• Interpret current efficacy and safety data from trials that leveraged precision testing strategies among patients with advanced NSCLC
• Explain emerging therapies that target ROS1 and NTRK in development to manage patients with advanced NSCLC

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.